A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

Ibrutinib-Venetoclax

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia IBRUTINIB-VENETOCLAX Regimen CLL – Ibrutinib & Venetoclax Indication •
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib-Venetoclax-Ver1.1.pdf

Daratumumab SC Ver1

Description
Chemotherapy Protocol Myeloma Daratumumab Subcutaneous Regimen • Myeloma – Daratumumab (SC) Indication • Daratumumab m
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Daratumumab-SC-Ver1.pdf

DRD Daratumumab-Lenalidomide-Dexamethasone

Description
Chemotherapy Protocol Myeloma DRD Daratumumab-Lenalidomide-Dexamethasone Regimen • Myeloma – DRD Daratumumab-Lenalidom
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DRD-Daratumumab-Lenalidomide-Dexamethasone.pdf

DVdSC (weekly cycles1-8) Bortezomib-Daratumumab-Dexamethasone Ver1

Description
Chemotherapy Protocol Myeloma DVd SC (weekly cycles 1-8) Bortezomib-Daratumumab-Dexamethasone Regimen • Myeloma –
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles1-8-Bortezomib-Daratumumab-Dexamethasone-Ver1.pdf

DVd-T SC Bortezomib-Daratumumab-Dexamethasone-Thalidomide v1

Description
Details of the Chemotherapy Protocol for Myeloma.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-T-SC-Bortezomib-Daratumumab-Dexamethasone-Thalidomide.pdf

Asciminib

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Asciminib Regimen • Asciminib Indication • Patients w
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Asciminib.pdf

CladribineSC

Description
Chemotherapy Protocol HAIRY CELL LEUKEMIA CLADRIBINE (SC) Regimen • HCL – Cladribine (SC) Indication • Hairy cell leukemia Toxicity Drug Cladribine Adverse Effect Ski
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/HCL/CladribineSC.pdf

DVdSC (weekly cycles 9 onwards) DaratumumabSC-Bortezomib-Dexamethasone Ver1

Description
Chemotherapy Protocol Myeloma DVd SC (weekly) Bortezomib Daratumumab Dexamethasone Cycles 9 onwards Regimen • Myel
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles-9-onwards-DaratumumabSC-Bortezomib-Dexamethasone-Ver1.pdf

Induction of labour - patient information

Description
Induction of labour Contents What is induction of labour? page 3 Reasons for induction page 3 If you are 12 days over your due date pa
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Induction-of-labour.pdf

Peptide receptor radionuclide therapy (PRRT) - patient information

Description
This factsheet explains what peptide receptor radionuclide therapy (PRRT) is, what the therapy involves, and what the possible benefits and risks
Url
/Media/UHS-website-2019/Patientinformation/Scansandx-rays/Peptide-receptor-radionuclide-therapy-PRRT-3016-PIL.pdf
1 to 10 of 353
Previous 1 2 3 4 5 … Next